This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...
JPMorgan Chase becomes the latest institution in the company's bull pen.
March S&P 500 E-Mini futures (ESH24) are down -0.04%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.11% this morning as market participants braced for the Federal Reserve’s first monetary policy...
Analysts have high hopes for these three innovation companies in 2024.
Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.
Wall Street is uber-bullish on these two Ark Invest holdings.
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
It has plenty of money, but it'll be facing plenty of competition, too.
These stocks could grow much larger over the next few years.
You might not get a better chance to invest in these disruptive companies.